20
May
2025
Adare Pharma Solutions
Exhibitor at CPHI Americas 2025 stand 1312
About Us
Categories
-
US -
2015On CPHI since
-
2Certificates
-
500 - 999Employees
Company types
Primary activities
Contact info
-
-
-
7722 Dungan Road, 19111, Philadelphia , Pennsylvania , United States
Event information
CPHI Americas 2025
-
20 May 2025 - 22 May 2025
-
Pennsylvania Convention Center, Philadelphia
-
Visit us at stand 1312
Products Featured at CPHI Americas 2025
-
Product Manufacturing Capabilities
Standard Offerings
• Granulation & Mixing • Fluid Bed Processing & Drying • Hot Melt Extrusion • Pan Coating • Blending • Tableting • Multi-layer Tablets • Capsule Filling • Oven Drying • Small-scale GMP Manufacturing ... -
Product Development Services
Comprehensive R&D Services • Preformulation • Formulation Development of Solid Dose Tablets (Capsules, Liquids & Solutions) • Pediatric Formulation • Product Design • Formulation Optimization • Sourcing of APIs & Excipients • Analytical Method Development & Validation • ... -
Product Technologies
Adare’s industry-leading experts possess unparalleled experience in the development of unique dosage forms that provide taste masking, customized release, and patient-centric solutions. Our technology platforms overcome complex formulation challenges to improve the lives of all patients, with expertise in ... -
Product Packaging
Clinical & Commercial Packaging Services
• Two FDA-Registered Packaging Facilities • A Full Range of Solid-Dose Packaging Solutions • High-Speed Bottle Filling • Blister Packaging • Stick Pack & Cartoning Operations • Packaging of DEA Schedules II, 2N, III, 3N, IV, L1 • Thermo &... -
Product Nitrosamine Mitigation
Very few CDMOs can claim Adare's level of experience in mitigating the presence of nitrosamine. We can employ our own-in-house mitigation processes to develop the best long-term control strategies for your product.
Regain control of your product with NitroCLEARx • Receive real-world mitiga... -
Product Adaptdose™
Adaptdose™, Adare’s unique commercialized approach to adaptive formulation design, is a highly flexible, multi-delivery platform tool that eliminates the need for post Phase 1 trial reformulations and facilitates the creation of custom oral delivery systems. Adaptdose provides the ability to combine 2-3 ac... -
Product CAT.one SM
CAT.one SM minimizes the potential for abuse by ensuring that drug products are evaluated for all potential routes of misuse. Adare’s experts integrate abuse-deterrent testing by replicating basic and multi-step methods that an abuser may use to prepare the product for recreational misuse or abuse. Our CAT... -
Product DIFFUTAB® Technology
DIFFUTAB® technology is an effective solution for targeted drug delivery through customized and sustained release. The technology assists the development of high-dosage and sustained release products for once-daily administration. A matrix tablet is coated with functional polymers, followed by a blend of h... -
Product Duragran™
Duragran™ allows for more uniformity and precise control of targeted particle sizes while providing production time and cost savings. It eliminates the need for extrusion and spheronization for high API-loaded drug particulates by using fluid bed processing technology that combines the particle sizing and ... -
Product Microcaps® Taste Masking and Modified Release Technology
Microcaps® Taste Masking and Modified Release Technology achieves uniform and efficient coating of drug particles by coacervation (phase separation) to build polymeric membranes of varying porosity and thickness. The result is a free-flowing powder containing microencapsulated API (or API substrate) in a w... -
Product Precision Particle Fabrication™ Technology
Precision Particle Fabrication™ technology produces uniform microspheres and microcapsules with narrow size distribution and precise control over particle structure. The platform technology is flexible and customizable to accommodate a broad range of active ingredients, including small molecules, peptides ... -
Product Optimµm® Technology for Oral Delivery
The Optimµm® technology creates microspheres with high drug loading suitable for taste masking, enteric coatings, and extended release oral applications. The technology is capable of producing single- or double-layer particles in a one manufacturing step, lending to cost-effective creation of palatabl... -
Product Stratµm™ Technology for Injectable Delivery
The Stratµm™ technology, for injectable delivery, allows for precise control of particle size and composition enabling predictable injectable performance, which is critical for self-administration, extended release, and modified release applications with a narrow therapeutic index. Unlike other encapsu... -
Product Unisun® Technology for Otic Delivery
The Unisun® technology combines the use of encapsulated or free drug, along with a fast-film forming agent, which allows for low-cost, long-acting intratympanic delivery of a therapeutic. The technology allows for less frequent administrations than current therapies and is capable of sustaining drug le...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance